Inst Diagnosti Stock EBITDA

INDISA Stock  CLP 1,591  4.40  0.28%   
Inst Diagnosti fundamentals help investors to digest information that contributes to Inst Diagnosti's financial success or failures. It also enables traders to predict the movement of Inst Stock. The fundamental analysis module provides a way to measure Inst Diagnosti's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Inst Diagnosti stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Inst Diagnosti Company EBITDA Analysis

Inst Diagnosti's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Inst Diagnosti EBITDA

    
  28.05 B  
Most of Inst Diagnosti's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inst Diagnosti is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

According to the company disclosure, Inst Diagnosti reported earnings before interest,tax, depreciation and amortization of 28.05 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Medical Care industry. The ebitda for all Chile stocks is significantly lower than that of the firm.

Did you try this?

Run Global Markets Map Now

   

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Module

Inst Fundamentals

About Inst Diagnosti Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Inst Diagnosti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inst Diagnosti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inst Diagnosti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Inst Diagnosti

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inst Diagnosti position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inst Diagnosti will appreciate offsetting losses from the drop in the long position's value.

Moving together with Inst Stock

  0.67AAISA Administradora AmericanaPairCorr
  0.61AFPCAPITAL AFP Capital SAPairCorr

Moving against Inst Stock

  0.59CAP CAP SAPairCorr
The ability to find closely correlated positions to Inst Diagnosti could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inst Diagnosti when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inst Diagnosti - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inst Diagnosti to buy it.
The correlation of Inst Diagnosti is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inst Diagnosti moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inst Diagnosti moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inst Diagnosti can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Inst Stock

Inst Diagnosti financial ratios help investors to determine whether Inst Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Inst with respect to the benefits of owning Inst Diagnosti security.